ADMA - ADMA BIOLOGICS, INC.
16.54
0.160 0.967%
Share volume: 8,245,421
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$16.38
0.16
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 03-18-2025 | 05-07-2025 | 08-06-2025 | 11-05-2025 | 02-25-2026 | |
| Assets | |||||||||
| Total Assets | 350.875 M | 376.399 M | 390.618 M | 488.678 M | 510.569 M | 558.380 M | 568.687 M | 624.242 M | |
| Current Assets | 276.419 M | 303.691 M | 318.193 M | 331.410 M | 351.814 M | 399.563 M | 402.655 M | 466.512 M | |
| Inventories | 177.732 M | 179.810 M | 171.801 M | 170.235 M | 172.188 M | 191.464 M | 196.667 M | 206.465 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 6.530 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 45.325 M | 88.244 M | 86.707 M | 103.147 M | 71.625 M | 90.285 M | 61.385 M | 87.630 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 55.317 M | 54.326 M | 53.694 M | 54.707 M | 57.710 M | 57.501 M | 69.509 M | 65.057 M | |
| Other Assets | 19.139 M | 18.382 M | 18.731 M | 102.561 M | 101.045 M | 101.316 M | 96.523 M | 92.673 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 350.875 M | 376.399 M | 390.618 M | 488.678 M | 510.569 M | 558.380 M | 568.687 M | 624.242 M | |
| Total liabilities | 197.169 M | 188.130 M | 158.728 M | 139.660 M | 137.150 M | 160.055 M | 137.501 M | 146.922 M | |
| Total current liabilities | 53.088 M | 44.177 M | 44.891 M | 55.542 M | 53.498 M | 74.941 M | 56.490 M | 69.541 M | |
| Accounts Payable | 17.186 M | 14.179 M | 16.020 M | 20.219 M | 20.607 M | 29.769 M | 24.021 M | 22.519 M | |
| Other liabilities | 2.093 M | 2.078 M | 2.063 M | 1.673 M | 1.315 M | 940.000 K | 90.000 K | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 130.847 M | 131.074 M | 101.326 M | 72.337 M | 72.527 M | 73.397 M | 70.084 M | 69.330 M | |
| Other liabilities | 2.093 M | 2.078 M | 2.063 M | 1.673 M | 1.315 M | 940.000 K | 90.000 K | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 153.706 M | 188.269 M | 231.890 M | 349.018 M | 373.419 M | 398.325 M | 431.186 M | 477.320 M | |
| Common stock | 642.156 M | 644.657 M | 652.369 M | 657.601 M | 655.098 M | 660.933 M | 665.406 M | 671.063 M | |
| Retained earnings | -488.450 M | -456.388 M | -420.479 M | -308.583 M | -281.679 M | -247.460 M | -211.032 M | -161.653 M |